Post-approval research on existing medicines has improved patient outcomes and addressed unmet medical needs. In oncology, post-approval improvements to drugs reflect indications for additional cancer ...
Cyprus Mail on MSN
Cyprus posts weak R&D intensity while EU investment climbs
The European Union increased its research and development spending in 2024, while Cyprus remained among the weakest performers, according to new figures released by Eurostat. The EU’s total R&D ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback